COVID-19, from infection to cancer

COVID-19, from infection to cancer

Authors

  • Mohanna Khandan Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  • Mohammad Amin Khazeei Tabari Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran
  • Noosha Samieefar Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Nima Rezaei Tehran University of Medical Sciences, Tehran, Iran

Keywords:

COVID-19, SARS-CoV-2, Cancer, Tumor markers

References

(1) Tabari MAK, Khoshhal H, Tafazoli A, Khandan M, Bagheri A. Applying computer simulations in battling with COVID-19, using pre-analyzed molecular and chemical data to face the pandemic. Informatics in Medicine Unlocked. 2020;21:100458.

(2) Nepogodiev D, Bhangu A, Glasbey JC, Li E, Omar OM, Simoes JFF, et al. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. The Lancet. 2020;396(10243):27-38.

(3) Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. The American journal of emergency medicine. 2020;38(7):1504-7.

(4) Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. The Lancet Neurology. 2020.

(5) Jyotsana N, King MR. The impact of COVID-19 on cancer risk and treatment. Cellular and Molecular Bioengineering. 2020:1-7.

(6) Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi sarcoma. Nature reviews Disease primers. 2019;5(1):1-21.

(7) Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 2020;395(10224):575-90.

(8) Purut YE, Giray B, Gurbuz E. Effect of the coronavirus pandemic on tumor markers. Journal of Medical Virology. 2021.

(9) Garg A, Seeliger B, Derda AA, Xiao K, Gietz A, Scherf K, et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. European journal of heart failure. 2021;23(3):468-75.

(10) Francescangeli F, De Angelis ML, Zeuner A. COVID-19: a potential driver of immune-mediated breast cancer recurrence? Breast Cancer Research. 2020;22(1):117.

(11) Yang J, Li H, Hu S, Zhou Y. ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19. Aging. 2020;12(8):6518-35.

Downloads

Published

26-10-2022

Issue

Section

CORRESPONDENCE - SPECIAL COVID19

How to Cite

1.
Khandan M, Khazeei Tabari MA, Samieefar N, Rezaei N. COVID-19, from infection to cancer. Acta Biomed. 2022;93(5):e2022224. doi:10.23750/abm.v93i5.12882